<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">5443</item><item key="factors"><item><item key="GSM306872"><item key="TISSUE">Spleen</item></item></item><item><item key="GSM306873"><item key="TISSUE">spleen</item></item></item><item><item key="GSM306872"><item key="TISSUE">Spleen</item></item></item><item><item key="GSM306872"><item key="TISSUE">Spleen</item></item></item><item><item key="GSM306873"><item key="TISSUE">spleen</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">6</item><item key="summary_wrapped">Robust type I interferon (IFN-alpha/beta) production in plasmacytoid dendritic cells (pDCs) is critical for anti-viral immunity. Here we...</item><item key="pubmed_id">18758466</item><item key="geo_gse_id">E-GEOD-12218</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">5</item><item key="tags"><item>cell</item><item>dendritic</item><item>line</item><item>spleen</item><item>yellow fever</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">tlr-mediated-type-i-ifn-induction-in-pdcs-requires</item><item key="geo_id_plat">E-GEOD-12218_A-AFFY-45</item><item key="name">TLR-mediated type I IFN induction in pDCs requires the rapamycin-sensitive PI3K-mTOR-p70S6K pathway</item><item key="created">Nov.10, 2014</item><item key="summary">Robust type I interferon (IFN-alpha/beta) production in plasmacytoid dendritic cells (pDCs) is critical for anti-viral immunity. Here we demonstrated a role for the mammalian target of rapamycin (mTOR) pathway in regulating interferon production by pDCs. Inhibition of mTOR or the &#8216;downstream&#8217; mediators of mTOR p70S6K1,2 kinases during pDC activation via Toll-like receptor 9 (TLR9) blocked the interaction of TLR9 with the adaptor MyD88 and the subsequent activation of interferon response factor 7 (IRF7), resulting in impaired IFN-alpha production. Microarray analysis confirmed that inhibition of mTOR by the immunosuppressive drug  rapamycin suppressed anti-viral and anti-inflammatory gene expression. Consistent with this, targeting rapamycin-encapsulated microparticles to antigen-presenting cells in vivo resulted in a diminution of IFN-alpha production in response to CpG DNA or the yellow fever vaccine virus strain 17D.  Thus, mTOR signaling plays a critical role in TLR-mediated IFN-alpha responses by pDCs.  CpGA is a TLR9 agonist. pDCs were isolated from mouse spleen or human PBMC. The effect of rapamycin on pDCs IFN-alpha production as induced by TLR ligands was studied. The mechanism of rapamycin effect was dissected in RAW cell line.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-12218</item><item key="species">mouse</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-12218/samples/</item></data></biogps>
